A Grañena

1.3k total citations
46 papers, 956 citations indexed

About

A Grañena is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, A Grañena has authored 46 papers receiving a total of 956 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Hematology, 11 papers in Genetics and 11 papers in Oncology. Recurrent topics in A Grañena's work include Hematopoietic Stem Cell Transplantation (20 papers), Acute Myeloid Leukemia Research (12 papers) and Chronic Lymphocytic Leukemia Research (8 papers). A Grañena is often cited by papers focused on Hematopoietic Stem Cell Transplantation (20 papers), Acute Myeloid Leukemia Research (12 papers) and Chronic Lymphocytic Leukemia Research (8 papers). A Grañena collaborates with scholars based in Spain, Austria and Slovakia. A Grañena's co-authors include Eva González‐Barca, Jordi Carratalà, A. Fernández‐Sevilla, Francesc Gudiol, C Rozmán, S Tura, Lena Brandt, Leo F. Verdonck, Michèle Cavo and Thierry Façon and has published in prestigious journals such as New England Journal of Medicine, Neurology and European Journal of Cancer.

In The Last Decade

A Grañena

46 papers receiving 918 citations

Peers

Countries citing papers authored by A Grañena

Since Specialization

Citations

This map shows the geographic impact of A Grañena's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Grañena with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Grañena more than expected).

Fields of papers citing papers by A Grañena

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Grañena. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Grañena. The network helps show where A Grañena may publish in the future.

Co-authorship network of co-authors of A Grañena

This figure shows the co-authorship network connecting the top 25 collaborators of A Grañena. A scholar is included among the top collaborators of A Grañena based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Grañena. A Grañena is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Richter's syndrome after allogeneic stem cell transplantation for chronic lymphocytic leukaemia successfully treated by withdrawal of immunosuppression, and donor lymphocyte infusion 2003 ·Bone Marrow Transplantation ·Ignacio Español, Tomáš Büchler, Christelle Ferrá, David Gallardo, (unknown), Josep Sarrà, A Domingo, V. Romagosa, A Grañena	15
2	Combined isolation of CD34+ progenitor cells and reduction of B cells from peripheral blood by use of immunomagnetic methods 2002 ·Transfusion ·(unknown), (unknown), Félix Rueda, B Amill, Sergio Querol, Eva González‐Barca, Christelle Ferrá, A Grañena, Joan Garcı́a	4
3	Individually adjusted prophylactic donor lymphocyte infusions after CD34-selected allogeneic peripheral blood stem cell transplantation 2001 ·Bone Marrow Transplantation ·Christelle Ferrá, (unknown), David Gallardo, Maite Encuentra, (unknown), (unknown), (unknown), Josep Sarrà, (unknown), Joan Garcı́a, A Grañena	16
4	Combined positive and negative cell selection from allogeneic peripheral blood progenitor cells (PBPC) by use of immunomagnetic methods 2001 ·Bone Marrow Transplantation ·(unknown), (unknown), B Amill, Sergio Querol, Christelle Ferrá, A Grañena, Joan Garcı́a	10
5	Mitoxantrone, Etoposide, Carboplatinum and Ara-C Combination Therapy (Meca) in Refractory and Relapsed Acute Leukemia 2000 ·Leukemia & lymphoma ·(unknown), (unknown), David Gallardo, (unknown), (unknown), (unknown), (unknown), Juan José Múñoz, (unknown), A Grañena	11
6	Treatment with interleukin-2 (IL-2) and interferon (IFNalpha 2b) after autologous bone marrow or peripheral blood stem cell transplantation in onco-hematological malignancies with a high risk of relapse 1999 ·Bone Marrow Transplantation ·P Vivancos, A Grañena, Josep Sarrà	12
7	Autologous bone marrow transplantation for high risk acute lymphoblastic leukemia: clinical relevance of ex vivo bone marrow purging with monoclonal antibodies and complement 1999 ·Bone Marrow Transplantation ·A Grañena, Xavier Castellsagué, Isabel Badell, Christelle Ferrá, JUAN F MARTINEZ ORTEGA, Salut Brunet, (unknown), Anna Sureda, (unknown), A Valls, (unknown), Joan Garcı́a	22
8	Fatal Myofascial Necrosis Due to Imipenem-resistant Aeromonas hydrophila 1997 ·Scandinavian Journal of Infectious Diseases ·Eva González‐Barca, Carmen Ardanuy, Jordi Carratalà, Ana B. Sánchez, A. Fernández‐Sevilla, A Grañena	8
9	Pentoxifylline, ciprofloxacin and prednisone failed to prevent transplant-related toxicities in bone marrow transplant recipients and were associated with an increased incidence of infectious complications 1997 ·Bone Marrow Transplantation ·Christelle Ferrá, S de Sanjosé, (unknown), Francesc Martí, (unknown), Anna Sureda, Salut Brunet, David Gallardo, (unknown), Joan Garcı́a, A Grañena	43
10	Prospective study of 288 episodes of bacteremia in neutropenic cancer patients in a single institution 1996 ·European Journal of Clinical Microbiology & Infectious Diseases ·Eva González‐Barca, A. Fernández‐Sevilla, Jordi Carratalà, A Grañena, Francesc Gudiol	100
11	Refractory Anaemia with Hypereosinophilia and Clonal Abnormal Metaphases Detected only in the Neutrophilic Granulopoietic Series 1994 ·Acta Haematologica ·(unknown), S Woessner, (unknown), Lourdes Florensa, A Grañena	8
12	Early mortality in bone marrow transplantation for acute lymphocytic leukaemia a multivariate analysis of risk factors. 1994 ·PubMed ·M. Algara, A Valls, Jaume Marrugat, A Grañena	1
13	Hematological Recovery after Autologous Bone Marrow Transplantation in Acute Leukemia: Predictive Factors 1993 ·Journal of Hematotherapy ·(unknown), Jesús M. López Martí, (unknown), Jorge Sierra, (unknown), A Grañena, A Domingo, J Cubells, (unknown), Isabel Badell, (unknown), (unknown), (unknown)	4
14	Risk factors for early mortality in allogeneic bone marrow transplantation. A multivariate analysis on 174 leukaemia patients 1993 ·European Journal of Cancer ·(unknown), M. Algara, Jaume Marrugat, Enric Carreras, Jorge Sierra, A Grañena	10
15	[Bone marrow transplantation: indications, methods, and results]. 1993 ·PubMed ·A Grañena	2
16	Slow response to induction chemotherapy is an indicator of poor survival after bone marrow transplantation for acute lymphoblastic leukemia. The Leukemia Working Party of the European Group of Bone Marrow Transplantation (EBMT). 1992 ·PubMed ·Dietger Niederwieser, A Grañena, J Hermans, H. Kolb, F. E. Zwaan, A Gratwohl	21
17	Fractionated total body irradiation for bone marrow transplantation: Clinical results on 66 patients 1990 ·Radiotherapy and Oncology ·(unknown), (unknown), M. Algara, (unknown), A Grañena	3
18	[Support treatment in bone marrow transplantation]. 1985 ·PubMed ·A Grañena, Enric Carreras, (unknown), Roberto Mazzara, L. Puig, (unknown), C Rozmán	2
19	[Bone marrow lymphoid follicles in myelofibrosis compared with chronic myelogenous leukaemia (author's transl)]. 1979 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·(unknown), (unknown), A Grañena, (unknown), Evarist Feliú, C Rozmán	2
20	[Chronic lymphoid leukemia. Survival in relation to clinical stages. Statistical analysis of 95 cases (author's transl)]. 1979 ·PubMed ·C Rozmán, (unknown), M. Morey, (unknown), Evarist Feliú, A Grañena, (unknown), Benet Nomdedeu	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact